Cargando…
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
Adoptive immunotherapy using CAR-T cells is a promising curative treatment strategy for hematological malignancies. Current manufacture of clinical-grade CAR-T cells based on lentiviral/retrovirus transfection of T cells followed by anti-CD3/CD28 activation supplemented with IL-2 has been associated...
Autores principales: | Du, Li, Nai, Yaru, Shen, Meiying, Li, Tingting, Huang, Jingjing, Han, Xiaojian, Wang, Wang, Pang, Da, Jin, Aishun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220804/ https://www.ncbi.nlm.nih.gov/pubmed/34179083 http://dx.doi.org/10.3389/fmolb.2021.675179 |
Ejemplares similares
-
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021) -
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
por: Mika, Thomas, et al.
Publicado: (2020) -
Mapping CAR T-Cell Design Space Using Agent-Based Models
por: Prybutok, Alexis N., et al.
Publicado: (2022) -
Unlocking the potential of Tregs: innovations in CAR technology
por: Requejo Cier, Christopher J., et al.
Publicado: (2023) -
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival
por: Kalinin, R. S., et al.
Publicado: (2021)